Comparative analysis of diagnostic methods for the detection of Cryptococcus neoformans meningitis

Background Cryptococcosis is a devastating opportunistic infection in immunocompromised individuals, primarily in people living with HIV/AIDS. This study evaluated a protocol for the early diagnosis of meningitis due to C. neoformans, utilizing established molecular techniques from serum and CSF samples. Methods The 18S and 5.8S (rDNA-ITS) sequence-specific nested PCR assays were compared with direct India ink staining and the latex agglutination test for detection of C. neoformans in serum and cerebrospinal fluid (CSF) from 49 Brazilian suspected meningitis patients. Results were validated with samples obtained from 10 patients negative for cryptococcosis and HIV, and by analysis of standard C. neoformans strains. Principal findings The 5.8S DNA-ITS PCR was more sensitive (89–100%) and specific (100%) than the 18S rDNA PCR and conventional tests (India ink staining and latex agglutination) for identification of C. neoformans. While the 18S PCR exhibited a sensitivity (72%) similar to that of the latex agglutination assay in serum samples, it was superior to the latex agglutination assay when testing CSF, with a sensitivity of 84%. However, the latex agglutination was superior to the 18SrDNA PCR in specificity in CSF (92%). The 5.8S DNA-ITS PCR yielded the highest levels of accuracy (96–100%) of any test for detection (serological and mycological) of C. neoformans in both serum and CSF. Conclusion Use of the nested 5.8S PCR was superior to other techniques for the diagnosis of cryptococcosis. The possibility of using serum, a non-invasively collected material, in a targeted 5.8S PCR analysis to identify Cryptococcus spp. is recommended, especially in immunosuppressed patients. Our results indicate that nested 5.8S PCR can increase the diagnostic capability of cryptococcosis, and we suggest its use to monitor patients in the future.

[1]  D. Boulware,et al.  The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. , 2022, The Lancet. Infectious diseases.

[2]  S. Suerbaum,et al.  Comparison of a Lateral Flow Assay and a Latex Agglutination Test for the Diagnosis of Cryptococcus Neoformans Infection , 2021, Current Microbiology.

[3]  C. Vianna,et al.  Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil , 2021, Revista do Instituto de Medicina Tropical de Sao Paulo.

[4]  D. Boulware,et al.  Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis , 2021, Journal of clinical microbiology.

[5]  A. Bhigjee,et al.  Review of the neurological aspects of HIV infection , 2021, Journal of the Neurological Sciences.

[6]  P. Saldiva,et al.  A single-centre, retrospective study of the incidence of invasive fungal infections during 85 years of autopsy service in Brazil , 2021, Scientific Reports.

[7]  B. Kuehn Pulmonary Fungal Infections Affect Patients With COVID-19. , 2020, JAMA.

[8]  D. Boulware,et al.  The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017 , 2019, Open forum infectious diseases.

[9]  Adeno Gonçalves Oliveira,et al.  Mortality by cryptococcosis in Brazil from 2000 to 2012: A descriptive epidemiological study , 2019, PLoS neglected tropical diseases.

[10]  Wanshui Shan,et al.  Development of a lateral flow recombinase polymerase amplification assay for rapid and visual detection of Cryptococcus neoformans/C. gattii in cerebral spinal fluid , 2019, BMC Infectious Diseases.

[11]  L. Goldani,et al.  Molecular types of Cryptococcus species isolated from patients with cryptococcal meningitis in a Brazilian tertiary care hospital , 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[12]  D. Boulware,et al.  Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing , 2018, Journal of Clinical Microbiology.

[13]  S. Jaffar,et al.  Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Błaszkowska,et al.  Neuroinfections caused by fungi , 2018, Infection.

[15]  E. Castañeda,et al.  The status of cryptococcosis in Latin America , 2018, Memorias do Instituto Oswaldo Cruz.

[16]  D. Boulware,et al.  Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center , 2018, Revista do Instituto de Medicina Tropical de Sao Paulo.

[17]  O. Luiz,et al.  Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients , 2018, PloS one.

[18]  A. Limper,et al.  Fungal infections in HIV/AIDS. , 2017, The Lancet. Infectious diseases.

[19]  D. Boulware,et al.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. , 2017, The Lancet. Infectious diseases.

[20]  A. S. Borges,et al.  The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital , 2017, Revista do Instituto de Medicina Tropical de Sao Paulo.

[21]  Yue Zhao,et al.  Current diagnosis and treatment of cryptococcal meningitis without acquired immunodeficiency syndrome , 2016 .

[22]  D. Boulware,et al.  Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. , 2016, Medical mycology.

[23]  D. Boulware,et al.  LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.

[24]  K. Ashizawa,et al.  Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[25]  M. Martins,et al.  Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex , 2014, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[26]  Daniel Wagner Castro Lima Santos,et al.  Epidemiology of Invasive Fungal Infections in Patients with Acquired Immunodeficiency Syndrome at a Reference Hospital for Infectious Diseases in Brazil , 2014, Mycopathologia.

[27]  D. Castelo-Branco,et al.  Molecular methods for the diagnosis and characterization of Cryptococcus: a review. , 2010, Canadian journal of microbiology.

[28]  J. Perfect,et al.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Luiz Carlos Severo,et al.  Capítulo 3: criptococose pulmonar , 2009 .

[30]  I. Xess,et al.  Detection of Cryptococcus by conventional, serological and molecular methods. , 2009, Journal of medical microbiology.

[31]  L. Travassos,et al.  Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. , 2009, Memorias do Instituto Oswaldo Cruz.

[32]  S. Antinori,et al.  AIDS‐associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre‐ and post‐HAART eras. Experience of a single centre in Italy , 2009, HIV medicine.

[33]  M. Capoor,et al.  Clinical and mycological profile of cryptococcosis in a tertiary care hospital. , 2007, Indian journal of medical microbiology.

[34]  J. Heitman,et al.  Cryptococcus neoformans Mates on Pigeon Guano: Implications for the Realized Ecological Niche and Globalization , 2007, Eukaryotic Cell.

[35]  K. Kwon-Chung,et al.  Do major species concepts support one, two or more species within Cryptococcus neoformans? , 2006, FEMS yeast research.

[36]  A. Iwamoto,et al.  Utility of Testing Bronchoalveolar Lavage Fluid for Cryptococcal Ribosomal DNA , 2003, The Journal of international medical research.

[37]  M. Vainstein,et al.  Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. , 2003, FEMS yeast research.

[38]  E. Graviss,et al.  The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  B. Wanke,et al.  Serotyping of 467 Cryptococcus neoformans Isolates from Clinical and Environmental Sources in Brazil: Analysis of Host and Regional Patterns , 2003, Journal of Clinical Microbiology.

[40]  J. Graybill,et al.  Detection of Cryptococcus neoformans DNA in Tissue Samples by Nested and Real-Time PCR Assays , 2002, Clinical and Vaccine Immunology.

[41]  T. Boekhout,et al.  (1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae) , 2002 .

[42]  Y. Senda,et al.  Multiplex PCR Using Internal Transcribed Spacer 1 and 2 Regions for Rapid Detection and Identification of Yeast Strains , 2001, Journal of Clinical Microbiology.

[43]  K. Nishimura,et al.  New PCR Primer Pairs Specific for Cryptococcus neoformans Serotype A or B Prepared on the Basis of Random Amplified Polymorphic DNA Fingerprint Pattern Analyses , 1999, Journal of Clinical Microbiology.

[44]  P. Rappelli,et al.  Development of a Nested PCR for Detection ofCryptococcus neoformans in Cerebrospinal Fluid , 1998, Journal of Clinical Microbiology.

[45]  T. G. Mitchell,et al.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans , 1995, Clinical microbiology reviews.

[46]  T. G. Mitchell,et al.  Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans , 1994, Journal of clinical microbiology.

[47]  L. Ercolani,et al.  Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. , 1988, The Journal of biological chemistry.

[48]  William H. Barker,et al.  CLINICAL EPIDEMIOLOGY: THE ESSENTIALS. , 1984 .

[49]  A. Forrestel,et al.  CRYPTOCOCCOSIS , 1982, The Lancet.

[50]  K. Kwon-Chung,et al.  Epidemiologic differences among serotypes of Cryptococcus neoformans. , 1977, American journal of epidemiology.

[51]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[52]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .

[53]  J. Wilt,et al.  Medical Mycology , 1944, Nature.

[54]  C. Kauffman,et al.  Detection of cryptococcal antigen. Comparison of two latex agglutination tests. , 1981, American journal of clinical pathology.

[55]  L. Ajello,et al.  Laboratory manual for medical mycology. , 1962 .